Evidence map›Paper›PMID 40646448›Full record

ArticleBMC bioinformatics2025

An evaluation methodology for machine learning-based tandem mass spectra similarity prediction.

Michael Strobel, Alberto Gil-de-la-Fuente, Mohammad Reza Zare Shahneh, Yasin El Abiead, Roman Bushuiev, Anton Bushuiev, Tomáš Pluskal, Mingxun Wang

Abstract read
In one paragraph

Article in BMC bioinformatics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Observational
  2. Article
  3. Article
  4. Review
  5. Article
  6. Multispectrum ModiFinder Site Localization Performance.Journal of the American Society for Mass Spectrometry · 2025
    Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Michael StrobelDepartment of Computer Science and Engineering, University of California Riverside, 900 University Ave., Riverside, CA, 92521, USA.ORCID http://orcid.org/0009-0000-3829-0048
Alberto Gil-de-la-FuenteInformation Technologies Department, Escuela Politécnica Superior, Universidad San Pablo-CEU, CEU Universities, Urbanización Montepríncipe, Boadilla Del monte, 28668, Madrid, Spain.ORCID http://orcid.org/0000-0002-5951-1601
Mohammad Reza Zare ShahnehDepartment of Computer Science and Engineering, University of California Riverside, 900 University Ave., Riverside, CA, 92521, USA.ORCID http://orcid.org/0000-0002-5760-3190
Yasin El AbieadSkaggs School of Pharmacy and Pharmaceutical Science, University of California San Diego, 9255 Pharmacy Ln, San Diego, CA, 92093, USA.ORCID http://orcid.org/0000-0003-4392-7706
Roman BushuievInstitute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 542/2, Prague, 16000, Czech Republic.ORCID http://orcid.org/0000-0003-1769-1509
Anton BushuievCzech Institute of Informatics, Robotics and Cybernetics, Jugoslávských partyzánů 1580/3, Prague, 16000, Czech Republic.ORCID http://orcid.org/0009-0007-4783-6584
Tomáš PluskalInstitute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Flemingovo nám. 542/2, Prague, 16000, Czech Republic.ORCID http://orcid.org/0000-0002-6940-3006
Mingxun WangDepartment of Computer Science and Engineering, University of California Riverside, 900 University Ave., Riverside, CA, 92521, USA. mingxun.wang@cs.ucr.edu.ORCID http://orcid.org/0000-0001-7647-6097

Funding

NIH HHS 1R03OD034493-01NIH HHS NIH 5U24DK133658-02
6 · The paper itself

Abstract

backgroundUntargeted tandem mass spectrometry serves as a scalable solution for the organization of small molecules. One of the most prevalent techniques for analyzing the acquired tandem mass spectrometry data (MS/MS) - called molecular networking - organizes and visualizes putatively structurally related compounds. However, a key bottleneck of this approach is the comparison of MS/MS spectra used to identify nearby structural neighbors. Machine learning (ML) approaches have emerged as a promising technique to predict structural similarity from MS/MS that may surpass the current state-of-the-art algorithmic methods. However, the comparison between these different ML methods remains a challenge because there is a lack of standardization to benchmark, evaluate, and compare MS/MS similarity methods, and there are no methods that address data leakage between training and test data in order to analyze model generalizability.

resultIn this work, we present the creation of a new evaluation methodology using a train/test split that allows for the evaluation of machine learning models at varying degrees of structural similarity between training and test sets. We also introduce a training and evaluation framework that measures prediction accuracy on domain-inspired annotation and retrieval metrics designed to mirror real-world applications. We further show how two alternative training methods that leverage MS specific insights (e.g., similar instrumentation, collision energy, adduct) affect method performance and demonstrate the orthogonality of the proposed metrics. We especially highlight the role that collision energy plays in prediction errors. Finally, we release a continually updated version of our dataset online along with our data cleaning and splitting pipelines for community use.

conclusionIt is our hope that this benchmark will serve as the basis of development for future machine learning approaches in MS/MS similarity and facilitate comparison between models. We anticipate that the introduced set of evaluation metrics allows for a better reflection of practical performance.

Indexed as

Machine LearningTandem Mass SpectrometryAlgorithmsBenchmarkMachine learningMass spectrometryMetabolomicsSpectral similarity measure

Identifiers

PMID40646448
PMCPMC12247221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.